Krazati 200 mg Tablet

Krazati 200 mg Tablet

The Krazati 200 mg tablet is prescribed for adults diagnosed with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer. It is not for everyone, but for those patients who have already undergone a minimum of one systematic therapy. Moreover, it is confirmed by an FDA-approved test. You can take it with or without the food but twice daily or as prescribed by the doctor. The tablet helps to stop the cancer cell growth.

Category:

Description

SDO Pharmed manufactures and exports vital medicines like Krazati tablet in Dubai. We export them to countries like Germany, Canada, Russia, Saudi Arabia, and many more.

  • Share your complete medical history with the doctor.
  • Consult beforehand if you are pregnant or breastfeeding.
  • You may notice a few common temporary side effects.
  • However, consult the doctor if they persist.
  • Cooperation with the medical team if they ask for any tests.

Common Side Effects of the Krazati tablet

  • Nausea
  • Diarrhea
  • Fatigue, etc.

Reviews

There are no reviews yet.

Be the first to review “Krazati 200 mg Tablet”

Your email address will not be published. Required fields are marked *

Related products